Somatic mutations in myeloid transcription factors and in activated signaling genes predict the risk of treatment failure and progression to advanced phase in chronic myeloid leukemiaDennis Dong Huan Kim, Jiří Mayer, Daniela Žáčková et al.|Research Square|2023Cited by 0